Equities

Hims & Hers Health Inc

Hims & Hers Health Inc

Actions
  • Price (EUR)14.99
  • Today's Change0.02 / 0.13%
  • Shares traded70.00
  • 1 Year change+159.26%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 08:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments221180247
Total Receivables, Net5.713.233.58
Total Inventory222214
Prepaid expenses11104.61
Other current assets, total5.241.790.89
Total current assets265217270
Property, plant & equipment, net461613
Goodwill, net111111111
Intangibles, net192226
Long term investments------
Note receivable - long term------
Other long term assets0.090.030.04
Total assets441366421
LIABILITIES
Accounts payable433220
Accrued expenses289.1213
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total176.4647
Total current liabilities884879
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total8.696.666.75
Total liabilities975586
SHAREHOLDERS EQUITY
Common stock0.020.020.02
Additional paid-in capital712657614
Retained earnings (accumulated deficit)(368)(345)(279)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.12)(0.28)(0.14)
Total equity344312335
Total liabilities & shareholders' equity441366421
Total common shares outstanding213208205
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.